Physician profile
Joseph Davis
NPI 1659334936
$4,221.47
in general payments reported to CMS, 2019-2025
18 companies · $852 in 2025
The $852 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,165 · 2020: $389 · 2021: $390 · 2022: $282 · 2023: $383 · 2024: $760 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,970 · Travel and Lodging: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,970.28 |
| Travel and Lodging | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $849.50 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Endologix LLC | $615.62 | 2021-2025 | Endocross Device, Torus Stent Graft System |
| Abbott Laboratories | $563.24 | 2019-2023 | Supera, Jeti, Jeti Peripheral Catheter |
| Angiodynamics, INC. | $553.33 | 2019 | |
| Cook Medical LLC | $549.29 | 2019-2025 | Zilver Ptx, Cook |
| Silk Road Medical, INC. | $270.69 | 2019-2022 | |
| Bolton Medical INC | $205.95 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Bard Peripheral Vascular, INC. | $170.86 | 2020-2021 | |
| Cardiva Medical, INC. | $130.54 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic Vascular, INC. | $110.91 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $48.78 | 2024-2025 | |
| Medtronic, INC. | $34.05 | 2021-2025 | Endurant Iis |
| Terumo Medical Corporation | $30.34 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $22.47 | 2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $21.63 | 2024 | Camzyos |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $19.72 | 2019 | |
| Ethicon US, LLC | $13.35 | 2022 | |
| Philips North America LLC | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.